Sakar Healthcare Gestione

Gestione criteri di controllo 3/4

Sakar Healthcare Il CEO è Sanjay Shah, nominato in Feb2015, ha un mandato di 9.75 anni. possiede direttamente 0% delle azioni della società, per un valore di ₹ 28.64K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.1 anni e 4.2 anni.

Informazioni chiave

Sanjay Shah

Amministratore delegato

₹4.8m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	9.8yrs
Proprietà del CEO	0.0005%
Durata media del management	4.1yrs
Durata media del Consiglio di amministrazione	4.2yrs

Aggiornamenti recenti sulla gestione

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02

Recent updates

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Mar 23

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Feb 08

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Jan 10

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Dec 14

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Nov 22

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Sanjay Shah rispetto agli utili di Sakar Healthcare?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	₹124m
Jun 30 2024	n/a	n/a	₹112m
Mar 31 2024	₹5m	n/a	₹117m
Dec 31 2023	n/a	n/a	₹125m
Sep 30 2023	n/a	n/a	₹144m
Jun 30 2023	n/a	n/a	₹127m
Mar 31 2023	₹5m	n/a	₹128m
Dec 31 2022	n/a	n/a	₹178m
Sep 30 2022	n/a	n/a	₹139m
Jun 30 2022	n/a	n/a	₹144m
Mar 31 2022	₹5m	n/a	₹152m
Dec 31 2021	n/a	n/a	₹80m
Sep 30 2021	n/a	n/a	₹97m
Jun 30 2021	n/a	n/a	₹118m
Mar 31 2021	₹2m	n/a	₹107m
Dec 31 2020	n/a	n/a	₹118m
Sep 30 2020	n/a	n/a	₹122m
Jun 30 2020	n/a	n/a	₹106m
Mar 31 2020	₹2m	₹2m	₹96m
Dec 31 2019	n/a	n/a	₹88m
Sep 30 2019	n/a	n/a	₹86m
Jun 30 2019	n/a	n/a	₹78m
Mar 31 2019	₹2m	₹2m	₹67m

Compensazione vs Mercato: La retribuzione totale di Sanjay ($USD 56.85K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 42.61K ).

Compensazione vs guadagni: La retribuzione di Sanjay è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Sanjay Shah (65 yo)

9.8yrs

Mandato

₹4,800,000

Compensazione

Mr. Sanjay Surendra Shah has been Managing Director of Sakar Healthcare Limited since February 1, 2015. Mr. Shah serves as an Executive Director of Sakar Healthcare Limited since March 26, 2004 and serves...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Sanjay Shah	Chairman & MD	9.8yrs	₹4.80m	0.00046% ₹ 28.6k
Aarsh Shah	Joint MD & Executive Director	12.4yrs	₹3.60m	0.000060% ₹ 3.7k
Sunil Marathe	Technical Director & Whole Time Director	less than a year	₹1.20m	Nessun dato
Dharmesh Thaker	Chief Financial Officer	3.1yrs	Nessun dato	Nessun dato
Bharat Soni	Company Secretary & Compliance Officer	4.1yrs	Nessun dato	Nessun dato

4.1yrs

Durata media

34yo

Età media

Gestione esperta: Il team dirigenziale di SAKAR è considerato esperto (durata media dell'incarico 4.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Sanjay Shah	Chairman & MD	20.7yrs	₹4.80m	0.00046% ₹ 28.6k
Aarsh Shah	Joint MD & Executive Director	12.4yrs	₹3.60m	0.000060% ₹ 3.7k
Sunil Marathe	Technical Director & Whole Time Director	less than a year	₹1.20m	Nessun dato
Vishalakshi Chandramouli	Non-Executive Non-Independent Director	1.2yrs	Nessun dato	Nessun dato
Shailesh Patel	Non-Executive Independent Director	9.6yrs	Nessun dato	Nessun dato
Prashant Srivastav	Independent Non-Executive Director	9.6yrs	Nessun dato	Nessun dato
Hemendrakumar Shah	Independent Non-Executive Director	4.2yrs	Nessun dato	Nessun dato
Khyati Shah	Non-Executive Independent Director	less than a year	Nessun dato	Nessun dato
Jignesh Parikh	Non-Executive Independent Director	less than a year	Nessun dato	Nessun dato

4.2yrs

Durata media

54yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SAKAR sono considerati esperti (durata media dell'incarico 4.2 anni).

Sakar Healthcare Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2024

Insufficient new directors

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2023

Sakar Healthcare Limited, Annual General Meeting, Sep 20, 2022

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Recent updates

Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Second quarter 2025 earnings released: EPS: ₹2.17 (vs ₹1.68 in 2Q 2024)

New minor risk - Shareholder dilution

First quarter 2025 earnings released: EPS: ₹1.10 (vs ₹1.46 in 1Q 2024)

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2024

Full year 2024 earnings released: EPS: ₹5.64 (vs ₹6.86 in FY 2023)

Investor sentiment deteriorates as stock falls 15%

Third quarter 2024 earnings released: EPS: ₹0.98 (vs ₹2.16 in 3Q 2023)

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Second quarter 2024 earnings released: EPS: ₹1.68 (vs ₹1.01 in 2Q 2023)

Insufficient new directors

Investor sentiment improves as stock rises 20%

New major risk - Financial position

First quarter 2024 earnings released: EPS: ₹1.46 (vs ₹1.65 in 1Q 2023)

New major risk - Share price stability

Sakar Healthcare Limited announced that it expects to receive INR 599.999123 million in funding from Tata Investment Corporation Limited

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 27%

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2023

Full year 2023 earnings released: EPS: ₹6.59 (vs ₹8.90 in FY 2022)

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Third quarter 2023 earnings released: EPS: ₹2.16 (vs ₹0.07 in 3Q 2022)

Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Investor sentiment improved over the past week

Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Second quarter 2023 earnings released: EPS: ₹1.01 (vs ₹1.44 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹1.65 (vs ₹1.80 in 1Q 2022)

Sakar Healthcare Limited, Annual General Meeting, Sep 20, 2022

Investor sentiment improved over the past week

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Full year 2022 earnings released: EPS: ₹8.73 (vs ₹7.09 in FY 2021)

Investor sentiment improved over the past week

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹1.44 (vs ₹3.04 in 2Q 2021)

Full year 2021 earnings released: EPS ₹7.09 (vs ₹6.43 in FY 2020)

Investor sentiment deteriorated over the past week

With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹6.87 (vs ₹6.43 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Third quarter 2021 earnings released: EPS ₹1.20 (vs ₹1.48 in 3Q 2020)

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Investor sentiment improved over the past week

New 90-day high: ₹107

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Market bids up stock over the past week

New 90-day high: ₹91.65

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

First half earnings released

Market pulls back on stock over the past week

New 90-day high: ₹84.85

New 90-day high - ₹78.70

First quarter earnings released

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione